Study Maps Economic Fallout of NIH Cuts in Georgia

The Science & Community Impacts Mapping Project (SCIMaP) shows how proposed federal funding cuts lead to reduced economic activity and job losses nationwide.

Georgia faces severe economic consequences as the Trump administration plans significant cuts to indirect funding by the National Institutes of Health (NIH). According to the Science & Community Impacts Mapping Project, Georgia stands to lose approximately $327 million in funding and 1,414 jobs, with effects rippling through communities across the state. 

 

Georgia's projected $327 million loss is part of a broader national impact. According to the project's findings, nearly half of all U.S. counties will experience economic losses of at least $250,000, with more than 500 counties losing over $6.25 million in funding. 

 

Ripple Effects on Innovation and Healthcare 

Beyond immediate economic losses, the cuts threaten Georgia's position in biomedical innovation. The state has historically leveraged NIH funding to: 


  • Develop groundbreaking medical treatments
  • Establish biotechnology startups
  • Train the next generation of healthcare professionals and researchers
  • Address critical public health challenges 


The proposed cuts would affect not only our state's major research universities but also regional institutions and the communities they support throughout the state. For communities already facing economic challenges, the loss of research-related economic activity could exacerbate existing problems. 

 

Looking Forward 

The Science & Community Impacts Mapping Project provides a sobering look at what's at stake for Georgia's communities when research funding diminishes, highlighting how federal research investment creates economic value far beyond laboratory walls. 

September 11, 2025
Members are invited to join G2G’s Monthly GBG Reporting Service Webinar on September 18, 2025 . The first portion ( 12:00–12:30 PM ET ) is free and open to all, offering a high-level overview of current federal funding trends. The second half ( 12:30–1:00 PM ET ) is a premium consultation available only to Georgia Life Sciences members, offering direct access to G2G’s expert team—who have helped secure over $550 million in non-dilutive government funding since 2007. Register here: https://www.g2gconsulting.com/event/non-dilutive-funding-g2gs-monthly-gbg-reporting-service-webinar-14-3/2025-09-18/ Key opportunities this month include DARPA’s Expedited Research Innovation System for CBRN threat defense technologies, BARDA’s I-CREATE diagnostic funding and VANGUARD biomanufacturing tools development (each offering up to $200,000), NIAID tuberculosis and influenza research units (up to $1.5–$2.5 million annually), DoD’s $4 million Advanced Medical Monitor development through MTEC, and multiple SBIR opportunities for sensors and field-deployable diagnostics (up to $209,575 for Phase I awards). The September GBG report highlights 13 immunology and infectious disease opportunities, 10 cognitive and brain health programs, and several biotechnology and biomanufacturing initiatives across federal agencies including the Army, ARPA-H, BARDA, and NSF. Georgia Life Sciences members can access the complete 29-page report with detailed deadlines and eligibility requirements [insert link or portal instructions here]. GLS members can access the full 29-page report with deadlines and submission details by logging into your member portal.
By Maria Thacker Goethe September 5, 2025
Protecting U.S. Leadership in Agricultural Biotechnology
By Maria Thacker Goethe August 29, 2025
Celebrating the Next Generation of Scientific Breakthroughs in Georgia
MORE POSTS